The identification and epidemiology of meticillin-resistant  and  in patient rooms and the ward environment by unknown
RESEARCH ARTICLE Open Access
The identification and epidemiology of
meticillin-resistant Staphylococcus aureus and
Clostridium difficile in patient rooms and the
ward environment
Meredith C Faires1*, David L Pearl1, Olaf Berke1,2, Richard J Reid-Smith1,3 and J Scott Weese3
Abstract
Background: Research has indicated that the environment may play an important role in the transmission of
meticillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile in healthcare facilities. Despite the
significance of this finding, few data exist from longitudinal studies investigating MRSA and C. difficile contamination,
concurrently, in both patient rooms and the general ward environment. The objectives of this study were to determine
the prevalence of MRSA and C. difficile contamination in patient rooms and the ward environment and identify risk
factors associated with a surface being contaminated with these pathogens.
Methods: Environmental surfaces in patient rooms and the general environment in the medical and surgical wards of
a community hospital were sampled six times over a 15 week period. Sterile electrostatic cloths were used for sampling
and information pertaining to the surface sampled was recorded. MRSA isolates and C. difficile specimens were
obtained from hospitalized patients.
Enrichment culture was performed and spa typing or ribotyping was conducted for MRSA or C. difficile, respectively. Exact
logistic regression models were constructed to examine risk factors associated with MRSA and C. difficile contamination.
Results: Sixteen (41%) patient rooms had≥ 1 surfaces contaminated with MRSA and/or C. difficile. For 218 surfaces
investigated, 3.2% and 6.4% were contaminated with MRSA or C. difficile, respectively. Regression models indicated that
surfaces in rooms exposed to a C. difficile patient had significantly increased odds of being contaminated with C. difficile,
compared to surfaces in unexposed patient rooms. Additionally, compared to plastic surfaces, cork surfaces had
significantly increased odds of being contaminated with C. difficile. For 236 samples collected from the ward environment,
MRSA and C. difficile were recovered from 2.5% and 5.9% of samples, respectively. Overall, the majority of MRSA and
C. difficile strains were molecularly identified as spa type 2/t002 (84.6%, n = 11) and ribotype 078 (50%, n = 14),
respectively.
Conclusions: In patient rooms and the ward environment, specific materials and locations were identified as being
contaminated with MRSA or C. difficile. These sites should be cleaned and disinfected with increased vigilance to help
limit the transmission and dissemination of MRSA and C. difficile within the hospital.
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Background
In Canadian hospitals, the incidence of meticillin-
resistant Staphylococcus aureus (MRSA) infections and
colonization have increased 17-fold from 1995 to 2007
[1] and remains a leading cause for a range of opportun-
istic infections [1]. Similarly, Clostridium difficile infec-
tion (CDI) has also increased in incidence and severity
including a four-fold increase in attributed mortality
[2], and is the most commonly diagnosed cause of
healthcare-associated (HA) and antimicrobial-associated
diarrhea [3].
Patients are the main reservoirs of both these patho-
gens, but there is increasing evidence that the environ-
ment may play a significant role in the nosocomial
transmission of MRSA [4] and C. difficile [5]. The ability
of contaminated surfaces contributing to the transmis-
sion of nosocomial pathogens relies on several determi-
nants including the frequency at which surfaces are
contaminated, if levels of contamination are sufficiently
high to result in transmission, and the ability of patho-
gens to remain viable on various surfaces [6]. Research
has demonstrated that S. aureus [7] and C. difficile
spores [8] are able to survive and persist in the hospital
environment for months. As levels of environmental
contamination with these HA pathogens increase, the
prevalence of healthcare worker hand carriage also in-
creases [9,10]. Additionally, patients and visitors may
be contaminated from contaminated surfaces, creating
further potential for acquisition or transmission of
MRSA and C. difficile in the healthcare setting and the
community.
Studies investigating contamination of hospital sur-
faces have primarily focused on MRSA or C. difficile.
There has been limited research investigating environ-
mental contamination with both of these pathogens,
concurrently, in healthcare facilities. Furthermore, po-
tential associations or commonalities between environ-
mental contamination with MRSA and C. difficile, in
both patient rooms and the ward environment have not
been explored. Given the different sources of MRSA and
C. difficile contamination, nasal/wound versus fecal, and
different susceptibility to disinfectants, an understanding
of the epidemiology of MRSA and C. difficile in the en-
vironment, in parallel study, can help infer sources of
contamination and potential factors associated with con-
tamination. Subsequently, the data obtained from this
research can be used by hospital personnel to evaluate
hospital infection protocols and procedures.
The objectives of this investigation were to determine
the prevalence and identify risk factors associated with
MRSA and C. difficile contamination in patient rooms
and the general ward environment of a community hos-
pital and compare MRSA and C. difficile strains between
patients and the contaminated environment.
Methods
Study site
The participating healthcare facility is a 260-bed large
community hospital located in Ontario, Canada. Starting
in December 2010, environmental sampling of patient
rooms and the general hospital environment in the med-
ical and surgical wards was conducted during six visits
over a 15 week period. Sampling was conducted once a
week for three consecutive weeks during weeks 1–3
(visits 1–3) and weeks 13–15 (visits 4–6). During the
study period, the MRSA colonization and infection rate
ranged from 0.38 – 1.93 cases/1,000 patient days and
the CDI rate ranged from 0.19 – 0.83 cases/1,000 patient
days. Although a C. difficile outbreak did not occur dur-
ing the study period, the hospital did experience an
MRSA outbreak between weeks 8 and 13 and an influ-
enza outbreak between weeks 9 and 11. However, both
outbreaks occurred in wards not involved in this investi-
gation. For environmental sampling in patient rooms,
verbal consent from patients, or from a parent in the
case of a child, was required prior to sampling. Written
informed consent was not required as surfaces sampled
in patient rooms belonged to the hospital and sampling
of patient’s personal belongings was not conducted. The
University of Guelph and the hospital research ethics
boards approved this study.
Sampling
Sampling of environmental surfaces was conducted in
patient rooms and the ward environment of one surgical
ward and two medicine wards, identified as medicine A
and medicine B. Three different types of patient rooms
were sampled for contamination. An unexposed room
had a patient not identified with MRSA or CDI and was
not under isolation precautions. A C. difficile exposed
room had a patient identified with CDI, based on clinical
signs and a positive stool toxin ELISA test (Tox A/B
Quik Chek, TechLab, Blacksburg, Virginia, USA), and
was under isolation precautions. An MRSA exposed
room had a patient identified with an MRSA infection
and/or colonization, based on microbiological diagnosis,
and was under isolation precautions. In the participating
hospital, surveillance for MRSA is conducted based on
recommendations provided by a Provincial Infectious
Disease Advisory Committee [11]. Briefly, at the time of
hospital admission, patients identified as having an in-
creased risk for MRSA acquisition (e.g., specific risk fac-
tors, wounds, incisions, catheter sites) are screened. For
patients located on high risk units (e.g., intensive care
unit), universal admission screening is performed. Dur-
ing hospitalization, surveillance cultures are not rou-
tinely conducted. Furthermore, screening of catheter
sites are performed only if clinical signs of infection are
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observed or the patient is transferred to the continuing
care or rehabilitation wards.
For each MRSA and C. difficile exposed room that was
identified, two unexposed rooms were randomly sam-
pled on the same ward as the exposed room. In all pa-
tient rooms, six different surfaces were sampled
including the railing at the end of the bed, bulletin
board, chair back, overbed table, privacy curtain, and
television. For unexposed rooms, if more than one pa-
tient was present, the investigator randomly chose a pa-
tient and sampled the surfaces in that patient’s vicinity.
For the general ward environment, environmental sur-
faces sampled were those distributed over the ward and
located in nursing and physician work areas, hallways,
and visiting rooms. Surfaces were sampled 4–6 times
over the study period and prior to being cleaned by
housekeeping staff. In the participating facility, surfaces
located in the general ward environment and patient
rooms (excluding C. difficile exposed rooms), were
cleaned once a day using a quaternary ammonium com-
pound. In C. difficile exposed rooms, surfaces were
cleaned twice a day with bleach. Following discharge, all
patient rooms were subjected to a terminal clean with a
quaternary ammonium compound. In addition, C. difficile
exposed rooms were cleaned with bleach. No changes in
the hospital cleaning protocol on the surgical and medi-
cine wards were instituted during the study period.
Sterile electrostatic cloths (Swiffer™, Proctor and Gam-
ble, USA) were used for environmental sampling. Using
a gloved hand, the investigator wiped the electrostatic
cloth over half the environmental surface to be sampled,
up to a maximum of 20 cm × 20 cm. The cloth was then
placed in a sterile collection bag (Whirl-Pak®, Nasco,
California, USA). The investigator then used a second
cloth to sample the other half of the environmental sur-
face. Gloves were changed between each sampling. Dur-
ing each visit, two electrostatic cloths were not used for
sampling but were handled and processed in parallel, to
act as negative controls. Information collected with each
surface sampled included: visit number, hospital ward,
surface location, environmental surface sampled, and
type of surface material. From the hospital’s microbiol-
ogy laboratory, patient isolates identified as MRSA were
collected from culture plates using a culture swab with
Stuart’s media and stool samples from C. difficile patients
were also obtained. Isolates or specimens were obtained
from only patients that were hospitalized in the medicine
and surgical wards during the 15 week study period, irre-
spective of whether they were present in the wards on the
sampling date. Only one isolate per patient was analyzed.
Isolates from patients that were epidemiologically linked
to the MRSA outbreak were not collected. All specimens
submitted for MRSA or C. difficile testing were collected
at the discretion of medical personnel.
Processing
For MRSA, cloths were immersed in 30 ml of enrich-
ment broth containing sodium chloride (75 g/L), manni-
tol (10 g/L), tryptone (10 g/L), and yeast extract (2.5 g/L)
and incubated at 35°C, aerobically, for 24 hours. Following
incubation, a 5 μL aliquot of broth was inoculated onto
MRSA Chromogenic agar (BBL CHROMagar MRSA,
Becton, Dickinson and Company, Sparks, Maryland, USA)
and incubated, aerobically, at 35°C for 24–48 hours. Iso-
lates were identified as S. aureus by Gram stain, tube
coagulase test, catalase test, and the S. aureus latex
agglutination assay (Pastorex Staph-plus, Bio-Rad
Laboratories Ltd., Mississauga, Ontario, Canada).
Meticillin-resistance was confirmed by testing for the
penicillin-binding protein 2a (MRSA Screening Kit, Denka
Seiken, Campbell, California, USA). For patient isolates,
culture swabs were streaked onto blood agar (Oxoid,
Nepean, Ontario, Canada) and processed as described
above. Molecular typing of MRSA was conducted using
sequence analysis of the X region of the staphylococcal
protein A gene (spa typing) [12]. Sequences were ana-
lyzed using the eGenomics software [13] and the Ridom
system [14]. For eGenomics, spa types are reported
using a numerical system (e.g., spa type 2) whereas
Ridom spa types are reported using a numerical system
preceded by a ‘t’ (e.g., t002). All spa types were com-
pared to epidemic MRSA strains that are commonly
found in Canada [15]. These Canadian epidemic MRSA
strains are designated as CMRSA and should not be
confused with community-associated MRSA strains
which are designated as CA-MRSA. All MRSA isolates
were investigated for the lukF-PV gene encoding the
Panton-Valentine leukocidin toxin by real-time PCR
[16]. Molecular typing of the MRSA outbreak strain was
not conducted by the hospital.
For C. difficile, electrostatic cloths were immersed in
30ml of enrichment broth containing brain-heart infu-
sion (37 g/L) and 0.1% sodium taurocholate and incu-
bated at 37°C, anaerobically, for 5 days. A 2 ml sample
of broth was then alcohol shocked for one hour,
followed by centrifugation at 4,000 rpm for 10 minutes.
The resulting pellet was inoculated onto C. difficile
moxalactam-norfloxacin agar (Oxoid, Nepean, Ontario,
Canada) and incubated for 24–96 hours at 37°C, anaer-
obically. Colonies were confirmed as C. difficile based on
characteristic morphology, odour, and production of L-
proline-aminopeptidase (Prodisk, Remel, Lenexa, Kansas,
USA). For patient isolates, approximately 1 g of feces was
inoculated into 9 ml of enrichment broth and processed
as described previously. All isolates identified as C. difficile
were investigated for the presence of toxin A (tcdA) [17],
toxin B (tcdB) [18], and the binary toxin (cdtA) [19] genes
using PCR. Ribotyping was used to analyze all C. difficile
isolates [20]. When a ribotype pattern was identified as an
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international ribotype based on comparison to reference
strains, the appropriate numerical designation (e.g., 027)
was assigned. Alternatively, an internal laboratory designa-
tion was assigned. Toxinotyping [21] was also performed
on a representative of each toxigenic ribotype.
Statistical analysis
For patient rooms and the general ward environment,
the prevalence of MRSA and C. difficile contamination
was determined for ward, location, surface material, sur-
face sampled, and visit (ward only). Statistical models
were also constructed, using exact logistic regression, to
test for associations between the occurrence of environ-
mental contamination with MRSA or C. difficile and the
following predictor variables: ward, location, surface ma-
terial, surface sampled, and visit number (ward only).
Additionally, the overall prevalence of surfaces positive
for MRSA or C. difficile prior to (visits 1–3), and follow-
ing (visits 4–6), the MRSA and influenza outbreaks,
were compared using exact logistic regression. The
Spearman’s rank correlation test was used to identify
correlations between all independent variables. Variables
with a correlation of >0.8 were investigated and only the
variable that was more biologically plausible was in-
cluded in the model to avoid issues associated with
collinearity [22]. Due to the relatively low prevalence of
MRSA and C. difficile contamination in both patient
rooms and the ward environment, only univariable
models were constructed using exact logistic regression,
employing the score method to calculate the P-value
[23]. Compared to other computational methods, the
score method does not compute an equivalent confi-
dence interval; subsequently, only odds ratios (OR) and
P-values are presented. For significant independent vari-
ables with several categories, contrasts between categor-
ies were also examined. Descriptive statistics and
analyses were performed using Stata 11.0 (StataCorp LP,
College Station, Texas, USA). All tests were two-sided
and the significance level was selected at α = 0.05.
Results
Patient rooms
A total of 218 surfaces located in 26 unexposed rooms,
10 MRSA exposed rooms, and 3 C. difficile exposed
rooms, were sampled during the study period. The
prevalence of MRSA and C. difficile contamination in
each type of patient room by ward, surface material, and
surface sampled is presented in Table 1. Overall, the
highest prevalence of MRSA contamination occurred in
unexposed rooms and the highest prevalence of C. difficile
Table 1 Descriptive statistics of variables for MRSA and C. difficile contamination in patient rooms
Unexposed rooms (n = 26) MRSA exposed rooms (n = 10) C. difficile exposed rooms (n = 3) Overall Prevalence
Variablesa MRSA (%) C. difficile (%) MRSA (%) C. difficile (%) MRSA (%) C. difficile (%) MRSA (%) C. difficile (%)
General prevalence 6/149 (4.0) 9/149 (6.0) 1/52 (1.9) 1/52 (1.9) 0/17 (0) 4/17 (23.5) 7/218 (3.2) 14/218 (6.4)
Ward:
Medicine Ab 4/54 (7.4) 3/54 (5.6) 0/20 (0) 1/20 (5.0) 0/5 (0) 2/5 (40) 4/79 (5.1) 6/79 (7.6)
Medicine Bc 0/35 (0) 3/35 (8.6) 1/16 (6.3) 0/16 (0) No sampling No sampling 1/51 (1.9) 3/51 (5.9)
Surgeryd 2/60 (3.3) 3/60 (5.0) 0/16 (0) 0/16 (0) 0/12 (0) 2/12 (16.7) 2/88 (2.3) 5/88 (5.7)
Material type:
Cork 0/23 (0) 3/23 (13) 0/7 (0) 1/7 (14.3) 0/3 (0) 2/3 (66.7) 0/33 (0) 6/33 (18.2)
Fabric 0/26 (0) 0/26 (0) 1/8 (12.5) 0/8 (0) 0/2 (0) 0/2 (0) 1/36 (2.8) 0/36 (0)
Laminate 1/26 (3.8) 1/26 (3.8) 0/9 (0) 0/9 (0) 0/3 (0) 1/3 (33.3) 1/38 (2.6) 2/38 (5.3)
Plastic 5/74 (6.8) 5/74 (6.8) 0/28 (0) 0/28 (0) 0/9 (0) 1/9 (11.1) 5/111 (4.5) 6/111 (5.4)
Surface sampled:
Bulletin boarde 0/23 (0) 3/23 (13) 0/7 (0) 1/7 (14.3) 0/3 (0) 2/3 (66.7) 0/33 (0) 6/33 (18.2)
Chair backe 4/25 (16) 2/25 (8) 0/10 (0) 0/10 (0) 0/3 (0) 0/3 (0) 4/38 (10.5) 2/38 (5.3)
End of bed 1/26 (3.8) 1/26 (3.8) 0/10 (0) 0/10 (0) 0/3 (0) 1/3 (33.3) 1/39 (2.6) 2/39 (5.1)
Overbed tablee 1/26 (3.8) 1/26 (3.8) 0/9 (0) 0/9 (0) 0/3 (0) 1/3 (33.3) 1/38 (2.6) 2/38 (5.3)
Privacy curtaine 0/26 (0) 0/26 (0) 1/8 (12.5) 0/8 (0) 0/2 (0) 0/2 (0) 1/36 (2.8) 0/36 (0)
Televisione 0/23 (0) 2/23 (8.7) 0/8 (0) 0/8 (0) 0/3 (0) 0/3 (0) 0/34 (0) 2/34 (5.9)
n = number of rooms.
a Denominator is based on the number of surfaces in patient rooms that were tested.
b Total of 10 unexposed rooms, 4 MRSA exposed rooms, 1 C. difficile exposed room located in ward Medicine A.
c Total of 6 unexposed rooms, 3 MRSA exposed rooms, 0 C. difficile exposed rooms located in ward Medicine B.
d Total of 10 unexposed rooms, 3 MRSA exposed rooms, 2 C. difficile exposed rooms located in the surgical ward.
e Surfaces were not present in all patient rooms at the time of sampling.
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contamination occurred in C. difficile exposed rooms. A
total of 12 (46.2%) unexposed rooms were previously oc-
cupied by a MRSA patient. However, none of the surfaces
in these 12 rooms were contaminated with MRSA. During
the study period, none of the unexposed rooms were pre-
viously occupied by a C. difficile patient.
Seven MRSA isolates were recovered from patient
rooms in which two different spa types were identified;
both consistent with the CMRSA-2 strain (Table 2). For
C. difficile, four different ribotypes were identified among
the 14 isolates recovered, including internationally recog-
nized ribotypes 027 (n = 1) and 078 (n = 9) (Table 3).
For six patient rooms, more than one surface was con-
taminated with MRSA or C. difficile at the time of sam-
pling. One unexposed room had MRSA recovered on
two surfaces, with both MRSA isolates identified as spa
type 2/t002. For two unexposed rooms and two C. difficile
exposed rooms, C. difficile was recovered from two sur-
faces at the time of sampling. In three of these patient
rooms, the C. difficile isolates recovered from the two sur-
faces were molecularly indistinguishable and were identi-
fied as ribotype 078.
Results from the univariable analyses (Table 4) indi-
cated that the odds of a surface being contaminated with
C. difficile were significantly greater in a C. difficile ex-
posed room compared to an unexposed room. In addi-
tion, in patient rooms, the odds of a cork surface being
contaminated with C. difficile were significantly greater
than surfaces covered in plastic. For the dependent vari-
able, surfaces contaminated with C. difficile, statistically
significant contrasts were identified between C. difficile
exposed patient rooms versus MRSA exposed patient
rooms (OR 14.88; P = 0.012) and cork surfaces versus
fabric surfaces (OR 10.33; P = 0.009). For MRSA contam-
ination of surfaces in patient rooms, no variables were
identified as statistically significant.
General environment
Over the study period, 45 different environmental sur-
faces, for a total of 236 samples, were investigated for
MRSA and C. difficile contamination. On average, each
surface was sampled 5.2 times (range 4–6). Overall, 2.5%
(n = 6) and 5.9% (n = 14) of surfaces were contaminated
with MRSA and C. difficile, respectively. During the
study period, none of the control electrostatic cloths
tested positive for MRSA or C. difficile.
Data pertaining to the distribution of MRSA and C. dif-
ficile contamination per ward, surface location, surface
Table 2 Typing data for MRSA strains from patients and contaminated surfaces
spa typea Number of isolates Ridom spa typeb PVL gene CMRSA USA equivalent
Patient rooms: (n = 7)
2c 85.7% (6) t002 No 2 100
437d 14.3% (1) t003 No 2 100
General environment: (n = 6)
2 83.3% (5) t002 No 2 100
1 16.7% (1) t008 Yes 10 300
Patientse: (n = 46)
2f 65.2% (30) t002 No 2 100
437 13% (6) t003 No 2 100
Newg 6.5% (3) Not assigned No Not assigned Not assigned
1 4.3% (2) t008 Yes 10 300
7 2.2% (1) Not assigned No Not assigned Not assigned
12 2.2% (1) t062 No 2 100
23 2.2% (1) t548 No 2 100
771h 2.2% (1) t2104 Yes Not assigned Not assigned
New 2.2% (1) t3618 No Not assigned Not assigned
n = number of isolates.
PVL = Panton-Valentine leukocidin.
CMRSA = Canadian epidemic meticillin-resistant Staphylococcus aureus.
a spa types classified according to eGenomics (http://tools.egenomics.com).
b spa types classified according to the Ridom system (http://www.spaserver.ridom.de).
c Five isolates recovered from five unexposed rooms; one isolate recovered from one MRSA exposed room.
d One isolate recovered from one unexposed room.
e For three MRSA exposed rooms, the patient’s MRSA isolate was not collected.
f Five MRSA isolates are from MRSA exposed rooms that were sampled.
g One patient isolate from a MRSA exposed room.
h Patient isolate from a MRSA exposed room.
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material, and surface sampled are presented in Table 5.
Overall, the highest numbers of surfaces contaminated
with MRSA or C. difficile were located in nursing and
physician work areas or the hallway. Specifically, chairs
and counter tops were found to be contaminated with
MRSA. For C. difficile, surfaces identified with the most
contamination included chairs, computer keyboards, and
heating oven handles. However, no surfaces had in-
creased odds of contamination compared to other





Patient rooms: (n = 14)
078a 64.3% (9) V tcdA, tcdB, cdtA
MOH-AIb 21.4% (3) 0 tcdA, tcdB
027c 7.1% (1) III tcdA, tcdB, cdtA
MOH-Vc 7.1% (1) 0 tcdA, tcdB
General environment: (n = 14)
078 35.7% (5) V tcdA, tcdB, cdtA
027 14.3% (2) III tcdA, tcdB, cdtA
MOH-V 14.3% (2) 0 tcdA, tcdB
001 7.1% (1) 0 tcdA, tcdB
MOH-AG 7.1% (1) 0 tcdA, tcdB
MOH-T 7.1% (1) 0 tcdA, tcdB
MOH-U 7.1% (1) 0 tcdA, tcdB
UNK-2 7.1% (1) Not tested None
Patientsd: (n = 21)
027e 33.3% (7) III tcdA, tcdB, cdtA
MOH-C 14.3% (3) IX tcdA, tcdB, cdtA
CHP-Af 9.5% (2) XXIV tcdA, tcdB, cdtA
MOH-AD 9.5% (2) III tcdA, tcdB, cdtA
078 4.8% (1) V tcdA, tcdB, cdtA
CHP-C 4.8% (1) XXIV tcdA, tcdB, cdtA
CHP-D 4.8% (1) 0 tcdA, tcdB
MOH-M 4.8% (1) 0 tcdA, tcdB
MOH-Q 4.8% (1) XII tcdA, tcdB
MOH-V 4.8% (1) 0 tcdA, tcdB
MOH-Y 4.8% (1) III tcdA, tcdB, cdtA
n number of isolates.
tcdA = toxin A.
tcdB = toxin B.
cdtA = binary toxin.
a One isolate from four different unexposed rooms; one isolate from one
MRSA exposed room; two isolates each from two different C. difficile
exposed rooms.
b Isolates from two different unexposed rooms.
c Isolate from one unexposed room.
d For one C. difficile exposed room, C. difficile could not be isolated from the
patient’s specimen.
e One patient isolate from a C. difficile exposed room.
f One patient isolate from a C. difficile exposed room.
Table 4 Univariable regression analyses of variables
associated with MRSA or C. difficile contamination in
patient rooms







Ward Medicine A Referent 0.614





MRSA exposed 0.47 0.679
C. difficile exposed 1.06a 0.634




Surface sampled End of bed Referent 0.111
Bulletin board 1.18a 0.999
Chair back 4.39 0.200
Overbed table 1.03 0.999






Ward Medicine A Referent 0.884





MRSA exposed 0.31 0.301
C. difficile exposed 4.71 0.031




Surface sampled End of bed Referent 0.059
Bulletin board 4.03 0.131
Chair back 1.03 0.999
Overbed table 1.03 0.999
Privacy curtain 0.44a 0.494
Television 1.15 0.999
OR = odds ratio.
a Median unbiased estimates.
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surfaces for MRSA or C. difficile contamination based on
the univariable analyses (Table 6).
The distribution of MRSA and C. difficile contamination,
per visit, fluctuated during the study period (Figure 1). For
visits 5 and 6, MRSA was not recovered from the general
ward environment. The highest prevalence of C. difficile
contamination occurred during visit 4. Compared to the
time period prior to the hospital outbreaks, there was no
statistically significant increase in the odds of contamin-
ation with MRSA (OR 0.19; P = 0.213) or C. difficile (OR
1.02; P = 0.999) in the time period following the outbreaks.
Two different spa types were identified among the six
MRSA isolates collected from the general ward environ-
ment (Table 2). One isolate was identified containing the
PVL toxin gene and corresponded to CMRSA-10. For C.
difficile, eight different ribotypes were identified among
the 14 isolates (Table 3), including ribotypes 027 (n = 2)
and 078 (n = 5).
Only one surface was positive for MRSA and C. diffi-
cile on the same visit; a chair located in a nursing station
on medicine ward B. Heating oven handles located in
medicine ward A were contaminated with C. difficile on
two separate visits. Molecular characterization of these
C. difficile isolates revealed ribotypes 027 and 078.
Patient isolates
Data pertaining to MRSA and C. difficile isolates from
patients are presented in Tables 2 and 3, respectively.
For MRSA, a total of 46 patient isolates were collected,
representing nine different spa types, with spa type 2/
t002 being the most prevalent. In one MRSA exposed
room, the privacy curtain was contaminated with the
same MRSA spa type that was identified in the patient,
spa type 2/t002. Two patients were identified with
MRSA spa type 1/t008 during the study period. How-
ever, only one of these patients was present in the ward
when a chair located in the visiting room on the same
ward as the patient was identified as being contaminated
with MRSA spa type 1/t008. Although six patients were
identified with MRSA spa type 437/t003, none of these
patients were present in the surgical ward when a chair
located in an unexposed room was found to be contami-
nated with spa type 437/t003. Despite nine different
MRSA spa types identified in the patient population, six
of these spa types were not detected on surfaces located
in patient rooms or the ward environment.
For C. difficile, 22 patient specimens were collected
during the study period; however, C. difficile could not
be isolated from one patient specimen. For 21 C. difficile
isolates, 11 ribotypes were identified, with ribotype 027
being the most prevalent in the patient population. Dur-
ing visit 4, ribotype 078 was identified from the majority
of C. difficile contaminated surfaces located in patient
rooms and the general environment. However, only one
C. difficile patient was identified with ribotype 078 dur-
ing the study period. Although this patient was admitted
to the surgical ward shortly after visit 3, this patient was
not present in the hospital during visit 4. Ribotype MOH-
V was identified from one patient specimen; however, this
patient was not present in the medicine or surgical wards
when MOH-V was identified in an unexposed room and
the ward environment. A total of seven C. difficile patients
were identified with ribotype 027 during the study period.
However none of these patients were admitted to the
medicine ward where ribotype 027 was found in an unex-
posed room and the ward environment. A total of eight
ribotypes identified from patient specimens were not re-
covered from the hospital environment.
Discussion
To our knowledge, this is the first study to explore
MRSA and C. difficile contamination, concurrently, in
Table 5 Descriptive statistics of variables for MRSA and
C. difficile contamination in the ward environment
Variablesa MRSA C. difficile
Ward:
Medicine A (n = 72) 5.6% (4) 8.3% (6)
Medicine B (n = 67) 1.5% (1) 4.5% (3)
Surgery (n = 97) 1.0% (1) 5.2% (5)
Surface location:
Nurses’ and physician work areas (n = 99) 1.0% (1) 6.1% (6)
Hallway (n = 109) 3.7% (4) 5.5% (6)
Visiting room (n = 28) 3.6% (1) 7.1% (2)
Surface material:
Fabric (n = 78) 2.6% (2) 6.4% (5)
Laminate (n = 15) 13.3% (2) 0% (0)
Plastic (n = 103) 1.9% (2) 6.8% (7)
Rubber (n = 17) 0% (0) 5.9% (1)
Wood (n = 23) 0% (0) 4.3% (1)
Surface sampled:
Chair (n = 55) 3.6% (2) 7.3% (4)
Clean linen (n = 15) 0% (0) 6.7% (1)
Clean towels (n = 16) 0% (0) 0% (0)
Computer keyboard (n = 55) 1.8% (1) 5.5% (3)
Counter top (n = 15) 13.3% (2) 0% (0)
Drug cart (n = 17) 0% (0) 5.9% (1)
Glove box holder (n = 13) 7.7% (1) 7.7% (1)
Hand rail (n = 17) 0% (0) 5.9% (1)
Heating oven handle (n = 17) 0% (0) 17.6% (3)
Patient chart (n = 16) 0% (0) 0% (0)
n = number of samples.
a Denominator is based on the number of surfaces in the general ward
environment that were tested.
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both patient rooms and the ward environment of a com-
munity hospital, longitudinally. The percentages of ex-
posed patient rooms that were found to be contaminated
with MRSA or C. difficile were lower compared to other
studies [24-27]. This contrast in results may have been at-
tributed to the number of patient rooms and surfaces in-
vestigated in addition to different sampling and culturing
methodologies used among the studies.
Surfaces located in rooms with a C. difficile patient
had increased odds of being contaminated with C. diffi-
cile compared to unexposed and MRSA exposed rooms,
an unsurprising result given the potential for infected
patients to contaminate their environment and the abil-
ity of C. difficile spores to survive in the hospital envir-
onment for months [8]. Interestingly, unexposed rooms
were also identified as having a large number of surfaces
contaminated with MRSA or C. difficile. Previous studies
have also reported the presence of these HA pathogens
on surfaces located in patient areas not occupied by
MRSA or C. difficile patients [25,27,28]. Reasons for the
extensive contamination of surfaces in unexposed pa-
tient rooms may include transfer of pathogens via hands
or fomites of staff, patients, and visitors; misclassification
of patient rooms due to unidentified colonization status
of individuals; or failure of routine cleaning and disinfec-
tion practices. Although MRSA and C. difficile are suscep-
tible to the disinfectants used in this facility, a quaternary
ammonium compound and bleach, respectively, inad-
equate cleaning and disinfection practices cannot be
Table 6 Univariable regression analyses of variables
associated with MRSA or C. difficile contamination in the
ward environment













Ward Medicine A Referent 0.185
Medicine B 0.26 0.368
Surgery 0.18 0.165





Location Hallway Referent 0.492
Visiting Room 0.97 0.999





Clean towels 1.77 0.999
Counter top 7.96 0.114















Ward Medicine A Referent 0.609
Medicine B 0.52 0.496
Surgery 0.59 0.531
Table 6 Univariable regression analyses of variables
associated with MRSA or C. difficile contamination in the
ward environment (Continued)





Location Hallway Referent 0.999
Visiting Room 1.32 0.999





Clean towels 0.58 0.999
Counter top 0.93a 0.593





a Median unbiased estimates.
b Clean linen, glove box holder, hand rail, patient charts.
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excluded. In a multicentre study conducted by Carling
and colleagues [29], only 49.5% (1748/3532) of high touch
surfaces located in intensive care units were identified as
being clean following terminal cleaning practices. Lastly,
rooms housing known MRSA or C. difficile-infected indi-
viduals have enhanced cleaning protocols compared to
other rooms, as a result, surfaces may not be cleaned as
rigorously or as often in unexposed rooms. These data
highlight the need for regular and proper cleaning of all
hospital areas, not just those known to house patients
with pathogens such as MRSA and C. difficile.
In patient rooms, the identification of MRSA or C. dif-
ficile on overbed tables, privacy curtains, and televisions
is consistent with the literature [24,30-36], and presum-
ably, any hand contact surface is at some degree of risk
for contamination. While understanding higher risk sites
is important, these data indicate the need for broad
cleaning and disinfection, including surfaces that often
receive less attention. In the present investigation, chairs
and bulletin boards were sampled in patient rooms as it
was noted that staff, patients, and visitors would move
chairs by grasping the top surface of the chair back. Sub-
sequently, MRSA and C. difficile were cultured from this
surface with all positive chair backs specifically located
in unexposed patient rooms. In unexposed and exposed
patient rooms, bulletin boards were negative for MRSA
but positive for C. difficile. Upon further investigation it
was determined that in rooms with a patient under iso-
lation precautions, tourniquets used for phlebotomies
were secured to the bulletin boards. As C. difficile has
been cultured from the skin of asymptomatic patients
[37] and from the skin of patients with CDI [37,38], it is
theorized that the tourniquets became contaminated
with C. difficile which subsequently contaminated the
bulletin board. Although results from the univariable
analyses indicated that bulletin boards, compared to the
end of the patient bed, were not significantly associated
with C. difficile contamination, cork surfaces, compared
to plastic and fabric surfaces, had significantly increased
odds of being contaminated with C. difficile. In this in-
vestigation all bulletin boards in patient rooms were
made of cork, a porous material with an irregular sur-
face. Due to the surface characteristics of cork, which
make this material difficult to clean and disinfect, and
the likelihood that bulletin boards were rarely, if ever
disinfected, it is possible that bulletin boards may have
acted as a source of C. difficile dissemination in patient
rooms. It is not clear why MRSA was not recovered
from any of the bulletin boards in this investigation
since phlebotomy tourniquets have also been docu-
mented as acting as a reservoir for MRSA [39].
Overall, 2.5% and 5.9% of surfaces in the ward envir-
onment were contaminated with MRSA or C. difficile,
respectively. However, in the literature, the prevalence of
Figure 1 Distribution of MRSA and C. difficile contamination in the ward environment by week and visit. The arrow indicates when an
MRSA outbreak (weeks 8–13) and an influenza outbreak (weeks 9–11) occurred in the hospital. N = number of surfaces sampled.
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MRSA and C. difficile contamination of the general hos-
pital environment is extremely variable [4,28,40-44] and
therefore difficult to compare results between studies.
These differences in prevalence may be attributed to dif-
ferent study designs as well as the presence and number
of MRSA and C. difficile patients during the study
period.
In the general ward environment, surfaces covered in
fabric, laminate, or plastic had the highest level of MRSA
or C. difficile contamination; however there was no sta-
tistically significant association between type of material
and contamination. As these materials can vary widely
in their texture, they can pose a substantial problem
with respect to cleaning and disinfection, and therefore
act as potential sources of MRSA and C. difficile trans-
mission and dissemination. Staphylococcus aureus is able
to survive adverse environmental conditions and persist
in the hospital environment [45] including surviving in
hospital dust for nearly a year [7]. Experiments con-
ducted using swatches of fabric and plastic have demon-
strated that staphylococci can survive days to months
after drying on these types of materials which are com-
monly found in the hospital environment [46]. In
addition, C. difficile spores are highly resistant to envir-
onmental effects and many commonly used disinfectants
[47,48], which can result in their survival for months to
years in the hospital environment, unless physically re-
moved or exposed to an adequate disinfectant [8].
In the ward environment, countertops, heating oven
handles, computer keyboards, and chairs had the highest
prevalence of MRSA or C. difficile contamination; how-
ever, there was no statistically significant association be-
tween specific surfaces and contamination with either
pathogen. This lack of statistical association is in con-
trast to an earlier study investigating contamination in
the ward environment of three hospitals in which chairs,
hand rails, isolation carts, and sofas had significantly
greater odds for MRSA contamination compared to
computer keyboards [40]. However, in that particular
study, the prevalence of MRSA contamination was con-
siderably higher (11.8%) and the low prevalence of C.
difficile contamination (2.4%) did not allow for statistical
model construction. Nonetheless, results from the
present investigation demonstrate that contaminated
surfaces are common hand-touch sites that are fre-
quently touched by staff and/or patients and visitors.
Therefore, contamination may be attributed to lack of
hand hygiene, hand hygiene practices that are ineffective
at eliminating C. difficile spores, and/or inconsistent
cleaning and disinfection protocols.
During visits 3–6, C. difficile was identified as the pre-
dominant pathogen contaminating the ward environ-
ment. Although MRSA patients were present in the
medical and surgical wards for all six visits, C. difficile
patients were only present in the wards for visits 4–6.
For visit 4 (week 13), the prevalence of MRSA was rela-
tively small despite an MRSA outbreak during weeks 8–
13; however there was no significant association between
the prevalence of MRSA contamination prior to, and fol-
lowing, the outbreak. As the MRSA outbreak occurred
on a ward not involved in this investigation, the substan-
tial decrease of MRSA in the ward environment may
have been a result of overall increase in hand hygiene
and restricting patient movement and visitors to prevent
the outbreak spreading to other wards. Furthermore, an
influenza outbreak, which also occurred in a ward not
participating in this investigation, was declared during
weeks 9–11 of the study period. Following this outbreak,
the prevalence of C. difficile contamination in the ward
environment of the medical and surgical wards fluctu-
ated over the last three visits with a substantially higher
prevalence observed on visit 4; however, there was no
significant association between the prevalence of C. diffi-
cile contamination before and after the outbreak. This
increase in C. difficile contamination in the environment
during the latter part of this investigation may have been
attributed to the presence of C. difficile patients in the
study wards. However, research has demonstrated an as-
sociation between the presence of the influenza virus
and an increase in the incidence rate of CDI in hos-
pitalised patients during the winter months [49,50]. Pos-
sible factors contributing to this association include
antimicrobial use [49,50] and reductions in cleaning and
disinfection of non-outbreak wards because of increased
efforts directed towards outbreak wards. In the present
investigation, the monthly CDI incidence rate increased
from 0.73 to 0.83 cases/1,000 patient days following the
influenza outbreak. It is possible that patients with C.
difficile were not identified and isolated, or a focus on
influenza outbreak management led to decreased infection
control activities directed against C. difficile, subsequently
resulting in an increase in C. difficile contamination of the
general environment.
The predominance of spa types corresponding to
CMRSA-2, a sequence type 5 (ST5) clone, also known as
USA100, was not unexpected since it is the leading
cause of HA-MRSA in Canada [1,51]. The distribution
of MRSA strains in patient rooms, general ward areas,
and patients was similar, albeit with more apparent
strain diversity among patients than in the environment.
It is unclear whether this indicates that CMRSA-2 is
more adapted for surviving in the environment, as
strain-dependent environmental persistence has not
been investigated.
In total, 16 different toxigenic C. difficile ribotypes
were identified. Ribotype 027 was predominant in the
patient population and was the second most prevalent
ribotype identified contaminating the ward environment.
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This specific ribotype is responsible for various out-
breaks of CDI with increased severity, high relapse rates,
and significant mortality [52,53]. Despite its association
with outbreaks, this ribotype is also common in endemic
disease and was the second most prevalent strain in a
study of C. difficile isolates from Ontario diagnostic la-
boratories [54]. This is further evidence that while this
strain is of particular concern, ribotype 027 can be
present in patients and the environment in the absence
of a CDI outbreak. Yet, overall, C. difficile typing data in-
dicate less of a relationship between patient and environ-
mental strains than with MRSA. In particular, ribotype
078 accounted for 64% of isolates from patient rooms
and 36% from the ward environment but was identified
in only one patient. Increases in the incidence of CDI
caused by this particular strain have been reported inter-
nationally [55], including in Canada where 078 increased
from 0.5% of CDI isolates in 2004/2005 to 1.6% in 2008
[56]. The reason for the high prevalence of 078 in the
environment of this healthcare facility and the discord-
ance between environmental and patient prevalence is
not known. However, this particular ribotype is prevalent
among C. difficile strains isolated from food animals in
Canada [57-59] and was commonly identified in a study
of Ontario household environments [60]. The participat-
ing hospital serves a rural community, which may in-
crease the likelihood for exposure to 078 in the
community, with subsequent transmission into the hos-
pital. While ribotype 078 is referred to as a hypervirulent
strain, it is not likely as pathogenic or transmissible as
ribotype 027, based on fewer reports of severe disease or
outbreaks associated with 078. Therefore, it is plausible
that environmental contamination could occur more
readily than patient disease if ribotype 078 is more com-
mon in people in the community but less able to cause
disease, in comparison to ribotype 027. Given the lack of
surveillance data involving non-diarrheic individuals, it
is difficult to substantiate these hypotheses and more in-
formation is required regarding the epidemiology of this
potentially emerging strain and the potential role of
non-CDI patients, visitors, and staff in the contamin-
ation of the hospital environment.
The prevalence of toxinotype variants (toxinotypes
other than toxinotype 0) in patients was striking, with
only 14% of isolates belonging to toxinotype 0. The high
prevalence and diversity of toxinotype variants seen in
our study hospital have not been reported previously in
a patient population and is in contrast with an earlier
multicentre study in the province where ribotype 001, a
toxinotype 0 strain, was most common (25.5%) [54].
Similarly, the high prevalence of patient strains pos-
sessing the binary toxin strain (81%) was remarkably
high. This toxin is most commonly found in hyper-
virulent strains, although it is not clear whether it is an
important virulence factor or simply just commonly
present in strains that are more virulent.
This study has several limitations. For C. difficile, sev-
eral ribotypes present in the hospital environment were
not identified from patient specimens. This discordance
may have been attributed to isolates not being collected
or patients with C. difficile not being identified because
of a lack of routine screening or the use of a diagnostic
test with moderate sensitivity [61,62]. In addition, not all
surfaces were sampled each visit since some surfaces
were cleaned just prior to our arrival for sampling.
Lastly, the number of MRSA and C. difficile exposed
rooms available for sampling was limited, which may
have resulted in a lack of power to identify significant
risk factors associated with surfaces being contaminated
with MRSA or C. difficile.
Conclusions
In conclusion, the results from this investigation offer
detailed information on MRSA and C. difficile contamin-
ation in the hospital environment. The identification of
specific surfaces, materials, and locations as having an
increased prevalence of MRSA and C. difficile contamin-
ation can be used by hospital personnel for surveillance
purposes to assess and implement effective control mea-
sures for reducing the transmission of MRSA and C. dif-
ficile within the healthcare setting. In addition, this
study demonstrates the variety of MRSA and C. difficile
strains that can be found in patient populations and the
hospital environment. Further research investigating the
persistence of specific MRSA and C. difficile strains in
the hospital environment may be warranted.
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